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Heterodimerization of Munc13 C2A domain with
RIM regulates synaptic vesicle docking and priming
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The presynaptic active zone protein Munc13 is essential for neurotransmitter release, playing
key roles in vesicle docking and priming. Mechanistically, it is thought that the C2A domain of
Munc13 inhibits the priming function by homodimerization, and that RIM disrupts the
autoinhibitory homodimerization forming monomeric priming-competent Munc13. However,
it is unclear whether the C2A domain mediates other Munc13 functions in addition to this
inactivation–activation switch. Here, we utilize mutations that modulate the homodimeriza-
tion and heterodimerization states to deﬁne additional roles of the Munc13 C2A domain.
Using electron microscopy and electrophysiology in hippocampal cultures, we show that the
C2A domain is critical for additional steps of vesicular release, including vesicle docking.
Optimal vesicle docking and priming is only possible when Munc13 heterodimerizes with RIM
via its C2A domain. Beyond being a switching module, our data suggest that the Munc13-RIM
heterodimer is an active component of the vesicle docking, priming and release complex.
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I
nformation processing in the central nervous system relies on
efﬁcient synaptic transmission. Neurotransmitter (NT) release
occurs at a specialized presynaptic release site, known as the
active zone (AZ), and depends on the availability of docked and
primed fusion-competent vesicles. The processes of docking,
priming and fusion rely on the function of speciﬁc proteins
at the AZ. Loss-of-function studies in Caenorhabditis elegans,
Drosophila melanogaster and mammalian synapses have identi-
ﬁed several AZ protein families that play a key role in vesicle
docking and priming, including Munc13 (refs 1–6), CAPS4,7,
a-Liprin8, ELKS9 and RIM2,10–13.
Among these proteins, Munc13s and their homologues in
C. elegans and D. melanogaster are of particular interest because
they are absolutely crucial for both of these steps in the synaptic
vesicle (SV) cycle. In the mammalian central nervous system, the
Munc13 protein family comprises of four members: the most
prominently expressed Munc13-1, the two Munc13-2 isoforms
bMunc13-2 and ubMunc13-2, and Munc13-3 (ref. 14). Neurons
from Munc13-1/2 double knockout (DKO) lack of a measurable
ready releasable pool (RRP) and show no spontaneous or
Ca2þ -dependent evoked release1,6, similar to the observations
made in the corresponding unc-13 mutant in C. elegans15 and
in D. melanogaster dunc-13 mutant16. This absence of neuro-
transmission was initially attributed to events downstream
of SV docking, based on ultrastructural data from conventional
chemical ﬁxation1. However, reexamination of Unc13/Munc13
deﬁciency in C. elegans2,17,18 and mice3–5 using high-pressure
freeze ﬁxation revealed a loss of docked SVs, indicating that
Munc13 plays a role in the vesicle docking mechanism.
All Munc13s expressed at central synapses are large
multidomain proteins and share a well-conserved C-terminal
region, including a diacylglycerol (DAG) binding C1 domain,
a Ca2þ /phospholipid binding C2B domain, a MUN domain and
a C2C domain at the very C-terminal end. Biophysical studies
show that the Munc13 C terminus is crucial for membrane
fusion in reconstitution experiments that include the SNAREs,
Munc18-1, NSF (N-ethylmaleimide-sensitive factor) and a-SNAP
(a-soluble NSF attachment protein) because Munc13 and
Munc18-1 orchestrate SNARE complex assembly in an NSF/a-
SNAP-resistant manner19. Structure–function analyses revealed
that the C-terminal MUN domain is essential for vesicle priming
activity20–22 and mediates the activity of Munc13 by opening
syntaxin-1 (refs 23–25). Moreover, Munc13-1 fragment including
the C1C2B region preceding the MUN domain and the C2C
domain is critical for neurotransmitter release as they may help
bridge the SV and plasma membrane, that in turn facilitates
opening of syntaxin-1 (ref. 26). In addition, the C1 (refs 27–29)
and C2B domain30 are important regulators of vesicle release
probability and short-term plasticity, modulating vesicle fusion
efﬁciency through interaction with the plasma membrane in a
DAG- or Ca2þ /phospholipid-dependent manner.
The Munc13 N terminus, on the other hand, varies
considerably between the Munc13 isoforms14. In C. elegans, the
long and short Unc13 isoforms differ in their regulation of both
vesicle location relative to Ca2þ channels and neurotransmitter
release kinetics31. In mammals, the N termini of the isoforms
Munc13-1 and ubMunc13-2 contain a calmodulin (CaM)-
binding sequence that regulates short-term plasticity32,33, and a
C2A domain that is not present in bMunc13-2 and Munc13-3.
Biochemical studies have demonstrated that the C2A domain
can form tight homodimeric complexes34 or alternatively, a
heterodimeric complex with the zinc-ﬁnger domain (ZF) of the
RIM protein that can bind to the SV protein Rab3 (ref. 35).
Based on functional studies of Munc13 C2A domain interactions,
two distinct roles have been proposed for this domain: the
recruitment of Munc13 to the presynaptic active zone36 and the
activation of Munc13 as prelude to vesicle priming activity37. In
the latter study, Munc13 homodimers were shown to be inactive
and priming incompetent, while competitive binding of RIM to
the C2A disrupted the Munc13 homodimer and activated vesicle
priming. Remarkably, either expression of an N-terminally
truncated Munc13 or a Munc13 with a C2A domain point
mutation that inhibits Munc13 homodimerization in RIM1/2
conditional DKO bypassed the requirement of RIM in vesicle
priming, suggesting that RIM only interacts with Munc13 to
disrupt the homodimer, and indicating that the active form of
Munc13 is the monomer. These ﬁndings further implied that the
Munc13/RIM complex does not play a role in priming itself and
that the Munc13 C2A domain merely acts as an inactivation–
activation switch. This model is surprising given that classical
electron microscopy (EM) studies of aldehyde-ﬁxed synapses
lacking all RIM1 and RIM2 isoforms12,13 and EM tomography
from high-pressure freeze synapses of unc-10 mutant in
C. elegans2,17,18 show a reduction in docked vesicles. Moreover,
the Munc13/RIM/Rab3 complex may play a direct role in
regulating release probability38. On the other hand, it is unclear
how the conversion of Munc13 from homodimers to monomers
or Munc13/RIM heterodimers affects other steps in the SV cycle:
does it only affect priming or also upstream processes, such as
vesicle docking, and downstream processes, such as release? Does
homodimerization have a functional role beyond maintaining
Munc13 in an inactive state? To clarify the role of the C2A
domain and the individual functions of Munc13 monomers,
Munc13/Munc13 homodimers and Munc13/RIM heterodimers,
we performed a structure–function analysis of the role of the C2A
domain of Munc13-1 in docking, priming and vesicular release in
mammalian central synapses.
Results
Munc13-1 C2A domain supports vesicle docking. The complete
loss of docked synaptic vesicles observed in electron tomography
and transmission electron microscopy (TEM) studies using
cryoﬁxation techniques on Munc13-1/2 DKO neurons3–5 clearly
demonstrate that Munc13s are involved in SV docking. The
interaction between the Munc13-1 C2A domain and the RIM ZF
domain39 and the proposed role of RIM in vesicle docking2,11–13
suggest that the function of Munc13-1 in vesicle docking could be
mediated by the interaction of the C2A domain with RIM.
To test this hypothesis, we performed gain-of-function rescue
experiments in Munc13-1/2 DKO cultures from murine
hippocampal neurons. Using lentiviral gene transfer, we
expressed three different mutants of Munc13-1. The ﬁrst was
Munc13-1 with a complete truncation of the N terminus
(Munc13-1 del 1–520), corresponding to the mutant published
previously37,39. The other two mutants were designed to test the
speciﬁc C2A domain function within the N terminus: one that
speciﬁcally eliminated the C2A domain and the subsequent
a-helix (Munc13 del 1–150), and another that incorporated the
C2A domain but eliminated the intermediate region spanning
from the end of the C2A domain to the region preceding the C1
domain (Munc13-1 del 151–520) (Fig. 1a). Munc13-1/2 DKO
neurons rescued with a full-length Munc13-1 protein (Munc13-1
wild type (WT)) served as our WT-positive control and
untransfected Munc13-1/2 DKO neurons served as negative
controls. All Munc13-1 deletion mutants were found at
presynaptic glutamatergic compartments, as indicated by the
green ﬂuorescent protein (GFP) signal detected at the
vesicular glutamate transporter 1 (VGLUT1)-positive synapses
(Supplementary Fig. 1a). Fluorescence intensity quantiﬁcation of
the GFP signal at the VGLUT1 compartments (Supplementary
Fig. 1b) showed that all three Munc13-1 deletion mutants were
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Figure 1 | The N-terminal C2A domain of Munc13-1 is necessary for proper docking of synaptic vesicles. (a) Domain structure of full-length Munc13-1
and mutant proteins rescued in Munc13-1/2 DKO hippocampal neurons. (b) Representative electron micrographs of synapses showing docked synaptic
vesicles (indicated by red arrows) from Munc13-1/2 DKO hippocampal cultures and DKO cultures rescued with the respective Munc13-1 WTand mutants.
Scale bar, 100 nm. (c) Plot of number of docked SVs. (d) Plot of AZ length in nm. Numbers in bar graphs represent the n values for each group.
Signiﬁcances and P values were determined by one-way analysis of variance (ANOVA) with Kruskal–Wallis test followed by Dunn’s post test. Values
indicate mean±s.e.m.; **Po0.01, ***Po0.001.
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expressed at similar or higher levels than WT. Furthermore, the
comparison of synaptic responses between Munc13-1þ /þ /
Munc13-2 / , Munc13-1þ / /Munc13-2 / and Munc13-
1þ /þ /Munc13-2 / overexpressing Munc13-1 WT neurons
did not reveal signiﬁcant changes in Ca2þ -evoked release or
priming activity, indicating that these synaptic properties do not
change when expression levels vary by B50% of WT levels
(Supplementary Fig. 2d). We also determined the degree of
colocalization of Munc13 and VGLUT1 signals by comparing
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Supplementary Fig. 1c shows that the three truncated mutants
differ only slightly from the WT and between each other,
although the mutants that lacked C2A domain tended to show
more diffuse signals in axons and neurites (Supplementary
Fig. 1a). The efﬁciency of the Munc13-1/2 DKO rescue was
robust, as synaptic responses reached 65% of the Ca2þ -evoked
release and 75% of the priming activity compared with the
Munc13-1þ /þ /Munc13-2 / neurons (Supplementary Fig. 2c).
To address the role of Munc13 C2A domain in vesicle docking,
we performed TEM on high-pressure frozen samples from the
Munc13-1/2 DKO and Munc13-1/2 DKO rescued with Munc13-1
WT or with the Munc13-1 C2A domain-deleted mutants. EM
analysis was performed on 40 nm sections and the number of
synaptic vesicles in physical contact with the plasma membrane at
active zones was counted. In line with previous studies3–5,
Munc13-1/2 DKO active zones were essentially devoid of docked
vesicles (0.2±0.04 docked vesicle/AZ), while the active zones of
the Munc13-1 WT-rescued synapses showed approximately 2
docked synaptic vesicles (1.62±0.11 docked vesicle/AZ). However,
synapses from DKO rescued with the two Munc13-1 mutants that
lacked the C2A domain, that is, the C2A domain (del 1–150) and
the N-terminus (del 1–520) truncations, showed a 42% reduction
in the number of docked SVs. In contrast, deletion of the
intermediate region of the N terminus that does not eliminate the
C2A domain (del 151–520) showed the same docking activity as
the Munc13-1 WT (Fig. 1b,c). We did not detect differences in
the number of SVs within 100 nm of the AZ, in the diameter of
the SVs or in AZ length between any of the groups (Fig. 1d and
Supplementary Table 1), demonstrating that synapse formation
was unaffected. We conclude that the C2A domain of Munc13-1
is required to maintain the full-sized pool of docked vesicles,
indicating an important positive modulation for docked synaptic
vesicles.
Munc13 C2A domain is critical for vesicle priming and release.
Impairment of SV docking is thought to negatively affect
downstream functions such as vesicle priming, a process of
making synaptic vesicle fusion competent and Ca2þ -triggered
release. To correlate docking to priming and fusion, we
assayed vesicle priming and release in the Munc13-1 mutants
using electrophysiological recordings in autaptic hippocampal
cultures40. Vesicle priming was estimated by determining the size
of the RRP. The RRP was quantiﬁed by integrating the transient
inward current induced by a 5 s pulsed application of hypertonic
sucrose solutions41.
As shown previously1, Munc13-1/2 DKO neurons neither
released neurotransmitter upon application of hypertonic sucrose
solution (left trace, Fig. 2a), nor exhibited measurable synaptic
output after action potential stimulation (left trace, Fig. 2c).
None of the deletion mutants fully rescued vesicle priming and
had differential effects on the action potential (AP)-evoked
excitatory postsynaptic current (EPSC). The Munc13-1 mutant
that conserves the C2A domain but lacks the intermediate
N-terminal region (del 151–520) only moderately altered RRP
size without affecting the AP-evoked EPSC. The Munc13-1
mutant that lacked the entire N terminus (del 1–520) caused a
50% reduction in RRP size, similar in extent to the reduction in
vesicle docking, but only a mildly altered AP-evoked response.
However, the mutant that lacked the C2A domain and the
subsequent a-helix (del 1–150) showed a severe 80% loss of
primed vesicles and evoked synaptic output (Fig. 2a–d).
The differential effects in vesicle priming and AP-evoked
release in several of the mutants suggests an additional role of the
Munc13 N terminus in neurotransmitter release probability.
Indeed, deletion of the intermediate region of the N terminus
(del 151–520) led to an increase in vesicular release probability
(Pvr), while truncation of the C2A domain (del 1–150) caused a
reduction in Pvr. Deleting both the C2A domain and the
intermediate region from the N terminus (del 1–520) exhibited
a relative increase in Pvr but did not reach statistical signiﬁcance
(Fig. 2e). Consistent with the observed alterations in vesicular
release probability, we found that truncation of the C2A domain
led to strong facilitation, while the Munc13-1 mutant lacking
the complete N terminus or the intermediate region displayed
enhanced depression compared with full-length Munc13-1
(Fig. 2f,g).
Overall, our functional analyses of the Munc13-1 deletion
mutants lead to two major ﬁndings. Firstly, the C2A domain plays
an important role in vesicle priming and release probability.
Secondly, the Munc13-1 N terminus must contain domains that
have both inhibitory and facilitatory effects on vesicle priming
and release probability, since the short truncation of the N
terminus (amino acids 1–150), including the C2A domain and
the subsequent a-helix, is not functionally equivalent to the
truncation of the entire N terminus (amino acids 1–520)
(Fig. 2i,j). This raises the hypothesis that the Munc13-1 N
terminus has other functions in addition to the C2A/RIM-
dependent activation switch.
Disruption of the homo- and heterodimeric complex of Munc13.
Biochemical and functional studies have shown that the Munc13-1
C2A monomers can interact either with another Munc13 C2A
domain to form a homodimer or alternatively with RIM to form a
heterodimeric complex34. Given the multiple functions of the
C2A domain of Munc13 in vesicle docking, priming and release
probability, we asked whether the Munc13 C2A domain functions
differentially depending on its interaction partner. Indeed, while
the Munc13 homodimer is thought to inhibit priming, disruption
of the Munc13 homodimer via RIM binding to the C2A domain
activates priming37. To further examine the consequences of
Munc13 C2A domain interactions on vesicle docking, priming
and release probability, we generated a set of point mutants in the
Munc13-1 C2A domain in which homodimerization and/or RIM
heterodimerization is disrupted (Fig. 3a). The K32E single point
mutant is known to disrupt Munc13-C2A homodimerization
without disrupting Munc13-C2A/ZF-RIM heterodimerization34.
Figure 2 | Impairment of RRP, EPSC and Pvr on truncation of the C2A domain in Munc13-1. (a) Representative traces of synaptic responses induced by
500mM sucrose from Munc13-1/2 DKO autaptic hippocampal cultures and DKO cultures rescued with the respective Munc13-1 WTand mutants indicated
above. (b) Plot of RRP charge of Munc13-1 mutants normalized (Norm.) to corresponding Munc13-1 WTdata. (c) Representative traces of AP-evoked EPSC
amplitudes recorded in autaptic hippocampal neurons from Munc13-1/2 DKO and DKO rescued with Munc13-1 mutants indicated above. (d) Plot of AP-
evoked EPSC amplitudes of Munc13-1 mutants normalized to corresponding Munc13-1 WT. (e) Plot of Pvr of Munc13-1 mutants normalized to
corresponding Munc13-1 WT. (f) Example traces of EPSC amplitudes in response to 2 APs separated by 100ms (10Hz) of DKO rescued with Munc13-1 WT
and mutants indicated above. (g) Graph showing average paired-pulse ratios calculated from the 2 AP-evoked EPSC amplitudes. WT rescue is shown as
black dotted line. (h–j) Correlation between primed synaptic vesicle and docked synaptic vesicle, AP-evoked EPSC amplitudes and vesicular release
probability from DKO neurons rescued with Munc13-1 WT and N-terminal deletion mutants. Numbers in plots are n values for each mutant group and
numbers above the dashed line are the corresponding WT n numbers. Error bars represent s.e.m. Signiﬁcances and P values were determined by one-way
analysis of variance (ANOVA) with Kruskal–Wallis test followed by Dunn’s post test. Values indicate mean±s.e.m.; *Po0.05; ***Po0.001; ****Po0.0001.
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To speciﬁcally disrupt Munc13-C2A/ZF-RIM heterodimerization
without affecting the homodimerization state, we designed
a double point mutation within the C2A domain (E128K) and
the subsequent a-helix (E137K) based on the crystal structure
of the Munc13-1 C2A domain bound to the RIM ZF
domain34 (Fig. 3b). Isothermal titration calorimetry (ITC)
showed that a WT Munc13-1 fragment containing the C2A
domain and the additional a-helix (residues 3–150) binds
robustly to the RIM ZF domain, while the Munc13-1 fragment
(3–150) with the double point mutation (E128K, E137K)
exhibited no detectable binding (Fig. 3c). Finally, a triple point
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E137K) was created to study the Munc13-1 function as monomer
(Fig. 3a).
We conﬁrmed the impairment of binding in these Munc13-1
C2A mutations using co-immunoprecipitation assays in HEK293
cells. To assess Munc13 homodimerization, we co-transfected a
C-terminally ﬂag-tagged Munc13-1 with Munc13-1 WT or each
of the three C2A point mutants, fused C terminally with the GFP.
The two homodimerization-disrupting mutants Munc13-1
(K32E) and Munc13-1 (K32E, E128K, E137K) failed to pull
down ﬂag-tagged Munc13-1, demonstrating that they do not
form C2A/C2A homodimers (Fig. 3d and Supplementary Fig. 3a).
To probe for Munc13-C2A/ZF-RIM heterodimerization, we
co-transfected HEK293 cells with Munc13-1 WT or the three
C2A point mutants GFP-tagged together with full-length RIM-1a
fused C terminally to a red ﬂuorescent protein (RFP). As
expected, Munc13-1 WT and the Munc13-1 (K32E) that favours
the heterodimerization state efﬁciently co-immunoprecipitated
RIM-1a. However, the two Munc13-C2A/ZF-RIM
heterodimerization-disrupting mutants ((E128K, E137K) and
(K32E, E128K, E137K)) exhibited a major disruption to RIM
binding (Fig. 3e and Supplementary Fig. 3b).
To determine the synaptic localization and expression of
the Munc13-1 rescue constructs, we analysed and quantiﬁed their
GFP signal at VGLUT1-positive compartments. The results
showed that all expressed mutant proteins exhibited presynaptic
localization (Fig. 3f and Supplementary Fig. 4). Quantiﬁcation of
the intensities of the GFP ﬂuorescence at VGLUT1-positive
compartments showed that the homodimerization-disrupting
mutants Munc13-1 (K32E) and (K32E, E128K, E137K)
have similar or higher expression levels than the WT, while the
heterodimerization-disrupting mutant Munc13-1 (E128K, E137K)
showed an B30% reduction in expression (Supplementary
Fig. 4b). The degree of colocalization of the mutant proteins
with VGLUT1 showed slightly increased colocalization for
the homodimerization-disrupting mutants Munc13-1 (K32E),
while the heterodimerization-disrupting mutants Munc13-1
(E128K, E137K) and (K32E, E128K, E137K) displayed decreased
colocalization. Accordingly, the latter two mutants tended to
show more diffuse signals in axons and neurites (Fig. 3f).
Our observation of the localization of the three protein
mutants at the presynaptic glutamatergic compartments suggest
that Munc13-1 can in principle co-exist as homodimer, monomer
and heterodimer with RIM. We then tested how the shift in the
equilibrium between these three states could affect their synaptic
function. The single point mutation (K32E) helps to study the
role of Munc13-1 in the Munc13/RIM heterodimeric state,
while the double point mutation (E128K, E137K) probes the
function of the Munc13-1 as a homodimer. The triple point
mutation (K32E, E128K, E137K) represents the monomeric state
(Fig. 3a).
Optimal SV docking requires Munc13 RIM heterodimer formation.
To assess the impact of the different states of Munc13
on vesicle docking, we analysed EMs of Munc13-1/2 DKO
synapses expressing the set of Munc13-1 C2A domain mutant
variants generated (Fig. 3a). Synapses that expressed the
homodimerization-disrupting mutant Munc13-1 (K32E) showed
docking activity comparable to Munc13-1 WT rescued synapses
(Fig. 4b,c). Munc13-1 (E128K, E137K), which favours the
homodimerization state and (K32E, E128K, E137K) which
restricts Munc13 to the monomeric state by impairing homo-
dimerization and Munc13-1/RIM heterodimerization both
showed a 40% reduction in docked SVs (Fig. 4b,c). No groups
showed changes in the number of SVs within 100 nm from the
AZ, in SV diameter or in the length of the AZ (Fig. 4d and
Supplementary Table 1). These results are consistent with the
impairment of vesicle docking observed with the Munc13-1
truncation mutants (Fig. 1b,c), and more importantly demon-
strate that the C2A domain-dependent modulation of vesicle
docking is not due to disruption of Munc13 homodimerization,
but depend on the ability of Munc13-1 and RIM to heterodimerize.
Heterodimeric Munc13 favours vesicle priming and release.
We next compared vesicle priming and neurotransmitter release
characteristics in autaptic hippocampal neurons. Rescue of
Munc13-1/2 DKO neurons with the homodimerization-
disrupting mutant Munc13-1 (K32E) showed full rescue of vesicle
priming, demonstrated by the measurement of the RRP size
(Fig. 5a,b), as well as for evoked release (Fig. 5c,d). Expression of
this mutant tended to increase the Pvr, although the difference
compared to WT was not signiﬁcant, suggesting that the
Munc13/RIM binding does not affect the fusogenic state of the
vesicles (Fig. 5e). In contrast, Munc13-1 (E128K, E137K) which
favors Munc13 C2A domain homodimerization, strongly
impaired vesicle priming and AP-evoked responses. Expression of
the triple point mutant Munc13-1 (K32E, E128K, E137K), which
arrests Munc13-1 in its monomeric state led to 50% reduced RRP
size and AP-evoked EPSC amplitudes without affecting Pvr
(Fig. 5a–e). Paired-pulse experiments showed that the second
EPSC amplitude was slightly facilitated in synapses expressing the
Munc13-1 (E128K, E137K) mutant which favours homo-
dimerization (Fig. 5f,g), but to a lesser extent than the C2A
truncation mutant (Fig. 2f,g). The homodimerization-disrupting
mutant Munc13-1 (K32E) showed mild depression compared
with the WT (Fig. 5e) that did not reach signiﬁcant difference.
The paired-pulse ratios of responses from synapses expressing the
monomeric Munc13-1 (K32E, E128K, E137K) did not differ from
those of the WT.
Together, our data show that Munc13-1 function in priming
and NT release is highly dependent on the interactions of its C2A
domain. The Munc13-1 (E128K, E137K) mutant, which is unable
Figure 3 | Point mutants in Munc13-1 C2A domain result in homodimeric and monomeric Munc13-1 and heterodimeric complex of Munc13-1 and RIM.
(a) Schematic representation of the predicted states of monomerization, homodimerization and heterodimerization resulting from the introduction of the
single point mutation (K32E), the double point mutation (E128K, E137K) and the triple point mutation (K32E, E128K, E137K) within the C2A domain of
Munc13-1. (b) Ribbon diagrams of the Munc13-1/RIM2a heterodimer with the Munc13-1 fragment containing the C2A domain (residues 3–150) in orange
and the RIM ZF domain (residues 82–142) in blue. Zinc atoms are shown as yellow spheres. The diagram in the top panel shows the overall structure of the
complex. The bottom left and right panels show the heterodimerization interface of the RIM2a ZF domain with the Munc13-1 C2A domain and C-terminal
a-helix, respectively. The mutated side chains are labelled. (c) ITC analysis of binding of WT (left) and double point mutant E128K/E137K (right) Munc13-1
C2A domain (residues 3–209) to the RIM ZF domain (residues 82–142). (d) Co-immunoprecipitation (CoIP) of Munc13-1-Flag in HEK293 cells transiently
double transfected with Munc13-1-Flag and WT or mutants Munc13-1 GFP tagged as indicated in the blot (top). (e) CoIP of RIM-1a in HEK293 cells
transiently double transfected with RIM-1a-RFP and Munc13-1 WT or mutants GFP tagged as indicated in the top blot (bottom). These results are
representative of three independent experiments. Molecular weights (kDa) are indicated on the left side and antibodies used for detection on the right side
of the blots. The antibody used for the pull down is shown on the top. (f) Maximum projection confocal images showing the presynaptic localization of WT,
single point mutation (K32E), double point mutation (E128K, E137K) and triple point mutation (K32E, E128K, E137K) Munc13-1 expressed in Munc13-1/2
DKO neurons. DKO hippocampal neurons were ﬁxed at 16 days in vitro (DIV) and counterstained with GFP and VGLUT1 antibodies. Scale bar, 10 mm.
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to interact with RIM to disassemble the C2A/C2A homodimers is
deﬁcient in vesicle priming and exhibit a tendency to facilitate
(Fig. 5h,i). In contrast, the Munc13-1 (K32E) mutant, which
promotes Munc13-C2A/ZF-RIM heterodimerization shows full
priming activity and evoked release. The direct comparison of the
data from the monomeric Munc13-1 (K32E, E128K, E137K) with
the heterodimeric Munc13-1 (K32E) mutant demonstrate that
Munc13 monomers are less efﬁcient in priming and neurotrans-
mitter release compared with Munc13-1/RIM heterodimers
(Fig. 5h,i).
C2A domain regulation acts upstream of C1 domain activation.
Our previous electrophysiological analysis of the Munc13-1 point
mutants that promote heterodimerization revealed a novel reg-
ulation of docking via the Munc13 C2A domain and a similar
effect on vesicular priming as that described by Deng et al.37 It is
known that the activation of the Munc13-1 C1 domain
potentiates vesicular release probability by increasing vesicle
fusogenicity29. To determine whether the observed modulation of
the C1 domain is still present in the C2A point mutants, we tested
how application of phorbol 12,13-dibutyrate (PDBu) affects the
regulation by the C2A domain.
We ﬁrst probed putative docking effects by exposing
Munc13-1/2 DKO neurons and DKO neurons rescued with
Munc13-1 WT or Munc13-1 C2A point mutants to PDBu. The
number of docked synaptic vesicles was quantiﬁed within each
group and compared with each corresponding PDBu-untreated
group. PDBu treatment did not cause a change in the number of
docked SVs in Munc13-1/2 DKO. The same effect was
observed on DKO synapses rescued with Munc13-1 WT or the
Munc13-1 C2A homodimerization- and heterodimerization-
disrupting mutants (Fig. 6a,b), suggesting that DAG/phorbol
ester binding to the Munc13-1 C1 domain does not affect the
docking process. Moreover, using electrophysiological recordings
we assayed vesicular priming in the DKO neurons expressing
Munc13-1 WT and C2A point mutants before and after treatment
with PDBu. We observed that the presence of PDBu did not
change the RRP size in any of the group tested (Fig. 6c). The lack
of effect of PDBu on vesicle docking and priming in all the groups
is consistent with a post-priming role of DAG/phorbol ester
binding to the Munc13-1 C1 domain29.
We ﬁnally examined the effect of PDBu treatment on
AP-evoked neurotransmitter release and Pvr of neurons
expressing the C2A homodimerization- and heterodimerization-
disrupting mutants. PDBu application rapidly potentiated
AP-evoked EPSC amplitudes in all the mutants. By comparing
the degree of potentiation, we observed stronger PDBu potentia-
tion in the C2A mutants tending towards lower initial Pvr,
and less potentiation in the C2A homodimer-disrupting mutant
Munc13-1 (K32E), which tend to have high initial Pvr (Fig. 6e).
Importantly, the absolute Pvr reached similar levels in the
presence of PDBu across all mutants (Fig. 6f). These observations
indicate that the activation of the C1 domain by DAG/phorbol
ester binding normalizes any regulation of the C2A domain on
release probability and deﬁnes the C1 domain regulation as
downstream of the C2A domain activity.
Discussion
Synaptic transmission efﬁciency is critical for enabling precise
information ﬂow for all brain functions. Munc13s act as master
regulators of various aspects of neurotransmitter release through
the multiple domains that deﬁne its long protein sequence. The
identiﬁcation of an interaction between the RIM N-terminal ZF
domain and the Munc13 C2A domain35,39, together with the
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Figure 4 | The Munc13-1/RIM heterodimer complex is optimal for
docking. (a) Scheme corresponding to the structure of the full-length
Munc13-1 (WT), homodimerization mutant (K32E), heterodimerization
mutant (E128K, E137K) and homo/heterodimerization mutant (K32E,
E128K, E137K) used for rescues in Munc13-1/2 DKO hippocampal neurons.
(b) Representative electron micrographs of synapses showing docked
synaptic vesicles (indicated by red arrows) from Munc13-1/2 DKO
hippocampal cultures and DKO rescued with the respective Munc13-1 WT
and mutants indicated above. Scale bar, 100 nm. (c) Plot of number of
docked SVs. (d) Plot of AZ length in nm. Numbers in bar graphs represent
the n values for each group. Signiﬁcances and P values were determined by
one-way analysis of variance (ANOVA) with Kruskal–Wallis test followed
by Dunn’s post test. Values indicate mean±s.e.m.; **Po0.01; ***Po0.001.
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domain42, suggested that the binary Munc13–RIM complex or a
ternary complex with involvement of Rab3 could play important
roles in docking and/or priming of SVs. However, the ﬁnding that
most of the priming defect observed in the absence of aRIMs can
be rescued by a N-terminally truncated ubMunc13-2 or by a
ubMunc13-2 with a point mutant at the C2A domain that impairs
homodimerization37, led to the proposal that the Munc13 C2A
domain acts solely as a switch. When two Munc13 C2A domains
homodimerize, vesicle priming and release is blocked, and
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Our study supports the proposal that disruption of the Munc13
homodimer by RIM is indeed critical for its function, but we also
show that the Munc13-1 C2A domain does not act merely
because a switch, because heterodimerization of the C2A domain
with RIM optimizes Munc13 function. Thus, by forming a
complex with RIM, the Munc13-1 C2A domain plays a number of
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Figure 6 | Activation of the C1 domain by DAG/phorbol ester is downstream of the regulation of C2A domain. (a) Representative electron micrographs
of synapses showing docked synaptic vesicles (indicated by red arrows) from Munc13-1/2 DKO synapses and DKO rescued with Munc13-1 WT. Scale bar,
200nm. (b) Plot of docked synaptic vesicles from the Munc13-1/2 DKO and DKO synapses rescued with Munc13-1 WT and Munc13-1 C2A
homodimerization- and heterodimerization-disrupting mutants with or without PDBu. (c) Plot of RRP charge of DKO neurons rescued with Munc13-1 WT
and Munc13-1 C2A homodimerization- and heterodimerization-disrupting mutants with or without PDBu. (d) Example traces of evoked EPSC amplitudes
from Munc13-1/2 DKO rescued with Munc13-1 WT in black and Munc13-1 that favours the homodimerization state E128K, E137K in blue (solid lines) and
their corresponding EPSCs after PDBu application (dotted lines). (e) Potentiation of AP-evoked EPSC amplitudes induced by 1 mM of PDBu. PDBu
amplitudes were calculated by normalizing the EPSC amplitude in PDBu with the preceding EPSCs recorded in control extracellular solution. (f) Vesicular
release probability Pvr for Munc13-1 WTand mutant rescues with or without PDBu. Numbers in bar graphs are n values for each group. Data are expressed
as mean±s.e.m. For each mutant group, signiﬁcance and P values were calculated by comparison with the non-PDBu-treated group using the unpaired
Student’s t-test: Mann–Whitney. ***Po0.001.
Figure 5 | Munc13-1/RIM heterodimerization is required for optimal vesicle priming. (a) Representative traces of RRP charges induced by 0.5M sucrose
from DKO rescued with Munc13-1 WT and point mutants indicated above. (b) Plot of RRP charge of the Munc13-1 mutant rescues normalized to WT
Munc13-1. (c) Representative traces of evoked EPSC amplitudes from Munc13-1/2 DKO rescues with Munc13-1 WT in black, Munc13-1 K32E in purple,
Munc13-1 E128K, E137K in dark blue and Munc13-1 K32E, E128K, E137K in light blue. (d) Plot of AP-evoked EPSC amplitudes of Munc13-1 mutant rescues
normalized to the corresponding Munc13-1 WT. (e) Calculated vesicular release probability Pvr in %. (f) Example traces of EPSC amplitudes in responses to
2 APs separated by 100ms (10Hz) from DKO rescues with Munc13-1 WT and mutants indicated above. (g) Graph showing average paired-pulse ratios
calculated from the 2 AP-evoked EPSC amplitudes. (h,i) Correlation between docked synaptic vesicles, primed synaptic vesicles and vesicular release
probability from DKO neurons rescued with Munc13-1 WTand Munc13-1 C2A homodimerization- and heterodimerization-disrupting mutants. Numbers in
bar graphs are n values for each group. Error bars represent s.e.m. For each mutant, group signiﬁcance and P values for (b,d,e,g) were calculated by
Kruskal–Wallis one-way analysis of variance followed by a multiple comparison Dunn’s post hoc test. Values indicate mean±s.e.m.; **Po0.01; ***Po0.001.
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important roles in SV docking, priming and neurotransmitter
release.
That Munc13 is indispensable in the mammalian vesicle docking
process has been demonstrated by recent 3D electron tomography
and TEM studies on high-pressure frozen Munc13-deﬁcient
synapses3–5. The complete loss of docked synaptic vesicles is in
agreement with results obtained in earlier studies using C. elegans
unc13-null mutants2,17,18. However, the mechanism of Munc13-
mediated docking remains to be determined. Our study shows that
efﬁcient SV docking and priming are closely linked to the
persistent formation of Munc13/RIM heterodimers. Due to the
fact that all the mutants showed synaptic responses and were
localized at VGLUT1-positive compartments, we suggest that
Munc13 can co-exist as a homodimer, a monomer and
heterodimer with RIM in the presynaptic terminal (Fig. 3a). The
equilibrium between these three states depends on the strength of
the interactions with either another Munc13 C2A domain or with
RIM. We utilized truncations of the Munc13-1 C2A or the N
terminus (Fig. 1), as well as three Munc13-1 C2A domain point
mutants that disrupt homodimerization and/or Munc13-1/RIM
heterodimerization (Fig. 4), and show that docking is fully rescued
in synapses expressing mutants that support heterodimerization.
Conversely, docking is reduced in synapses expressing the mutants
that lack the Munc13-1 C2A domain or disrupt Munc13-1 C2A–
RIM interaction (Figs 1 and 4). These observations not only
suggest that RIM activates Munc13 function by dissociating the
Munc13 dimers,37 but also the Munc13/RIM heterodimer complex
is required for full SV docking activity. Interestingly, SV docking is
only compromised by 40–50% when the interaction of the
Munc13-1 C2A domain with RIM is disrupted, in contrast to the
complete loss of vesicle docking in the absence of Munc13
(refs 3–5). Since deletion of the C2A domain or point mutants that
impair the RIM binding affect docking activity, but show difference
in expression levels, suggests that changes in Munc13 expression in
the presynaptic compartment are unlikely to be the main cause of
the effect seen in vesicle docking activity. However, Munc13/RIM
interaction may be essential for the docking process and the 50%
docking activity observed in the Munc13-1 (del 1–150), Munc13-1
(del 1–520), Munc13-1 (E128K, E137K) and Munc13-1 (K32E,
E128K, E137K) mutants, are the result of a local reduction of
Munc13 translocation at the AZ, given the proposed role of RIM
in recruitment of, Munc13 to the active zone36. In fact, all
constructs that prevented Munc13-1/RIM heterodimers had a clear
diffused axonal or dendritic signal compared with the WT
(Supplementary Figs 1 and Fig. 3f). Possibly Munc13 content is
reduced directly at the AZ that we are however not able to assess
with the resolution of our imaging method. Other alternatives that
could explain the remaining docking activity include, the existence
of other RIM/Munc13 interactions that are not mediated by the
Munc13-1C2A/RIM-ZF domains. Indeed, RIM protein was still
detected in the co-immunoprecipitation assays that utilized the
mutant described above (Fig. 3 and Supplementary Figs 3 and 5).
Or that disruption of Munc13/RIM/Rab3 tripartite complex
impairs vesicle docking11. Finally, the primary docking role of
Munc13 may be mediated via its C terminus by the membrane
bridging activity proposed by Liu et al.26 that may favour efﬁcient
formation of trans-SNARE complexes4,24,25 and be enhanced and
regulated by the C2A domain RIM interaction at the N terminus.
SV docking precedes priming and is therefore a prerequisite for
rendering fusion competent vesicles. Accordingly, we found that
all Munc13 truncations and point mutants that impaired vesicle
docking (Figs 1c and 4c) also had a vesicle priming defect (Figs 2b
and 5b), but the fact that the decreased SV docking did not
correspond to the same extent with the decrease in SV priming in
the case of the C2A deletion and homodimerization point
mutants suggest that docking is not necessarily equivalent to
vesicle priming (Figs 2h and 5h). In addition, our functional
analysis indicates that the formation of the Munc13-1 C2A/ZF
RIM heterodimer complex is the optimal conﬁguration for vesicle
priming and neurotransmitter release. The importance of the
heterodimerization of the C2A domain with RIM was apparent
when comparing the release properties of the single point mutant
(K32E), the Munc13-1 monomer that can bind to RIM, with
the triple point mutant (K32E, E128K, E137K), the Munc13-1
monomer that lacks RIM binding activity (Fig. 5e).
The underlying mechanism for the boosted function of the
Munc13/RIM heterodimer is unclear, but may require the
presence of Rab3 that can form a tripartite complex together
with Munc13-1 and RIM35. Rab3-deﬁcient synapses have been
found to have reduced vesicular release probability38, supporting
the hypothesis that the tripartite complex may have a boosting
function on release. Finally, we found that the activity of
Munc13-1/RIM complex is distinct and upstream of the
potentiation of vesicle release probability induced by the
binding of DAG/phorbol ester to the C1 domain (Fig. 6) that is
thought to contribute to short-term plasticity events27,43,44.
Thus, following basal vesicle docking and basal priming, the
vesicular release can be positively modulated by membrane
translocation driven by the DAG/C1 domain interaction.
Our structure–function analysis also provides further insights
into how the N terminus of Munc13 contributes to the regulation
of vesicle fusion efﬁciency. We found that the intermediate region
between the C2A and the C1 domains (residues 150–519) is a
novel negative regulator of vesicular release probability, as
deletion of residues 1–150 impairs release more strongly than
deletion of residues 1–520 (Fig. 2). This regulatory function is
probably not related to CaM binding, as disruption of the CaM-
binding activity does not change vesicular release probability and
instead causes accelerated depression during AP trains32,45.
Further structure–function analysis of the Munc13 N-terminal
region will be required to gain insights into the inhibitory
function. Nevertheless, the discovery of the inhibitory activity in
the intermediate region between the C2A and C1 domains help
explain the observation that deletion of the entire N-terminal
region leads to small changes in vesicle priming and release37.
Loss of release through the lack of the C2A domain together with
the disinhibition from the deletion of the N-terminus inter-
mediate region may prevent a net change in overall synaptic
output (Fig. 2).
Overall, our results revise the previous interpretation that the
C2A domain of Munc13 and the ZF domain of RIM protein are
dispensable for vesicle priming once Munc13 homodimers are
disrupted37. Our ﬁndings emphasize the positive impact of the
C2A domain of Munc13 to enable this protein to orchestrate,
through its dynamic interactions with RIM, a wide range of
modulatory operations to shape vesicle docking, priming and
fusion.
Methods
Munc13-1 rescues lentiviral constructs and virus production. Munc13-1
full-length, truncation, deletions and point mutants rescue construct were
generated from a rat Unc13a splice variant, similar to Unc13a (NM_022861) but
lacking the exons 48, 49 and 53. The complementary DNAs (cDNAs) were sub-
sequently cloned into a lentiviral shuttle vector under the control of a human
synapsin-1 promoter. To enable identiﬁcation of infected cells, Munc13-1 rescue
proteins were fused with ﬂuorescent protein tagged Venus. Concentrated lentiviral
particles were prepared as previously described46.
Autaptic hippocampal culture and lentiviral infection. Munc13-1/2 DKO mice
on a FVB/N background were used for all studies. Animal Welfare Committee of
Charite´—Universita¨tsmedizin and the Berlin state government agency for Health
and Social Services approved all protocols for animal maintenance and experiments
(license no. T 0220/09). Microislands of growth-permissive substrate (collagen and
poly-D-lysine) were printed onto 30mm round glass coverslips precoated with
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agarose type 4, using a stamp containing 200 200 mm spaced dots. Astrocytes
were plated at a density of 5,000 cells per cm2 onto the microdot-coated coverslips
to allow them to grow onto the growth-permissive substrate. Hippocampi were
dissected from embryonic day 18.5 Munc13-1/2 DKO mouse and enzymatically
treated with 25 units per ml of papain for 45min at 37 C. After enzyme digestion,
solution was exchanged for an inactivation solution containing albumin, trypsin
inhibitor and 5% fetal calf serum. Hippocampi were mechanically dissociated and
the neuron suspension was plated onto the astrocyte microislands at a ﬁnal density
of 300 cells per cm2. Neurons were incubated at 37 C for 13–16 days to mature
before initiating the experiments. For rescue experiments neurons were infected
24 h after plating with lentiviral vectors.
High-pressure freezing and EM. Munc13-1/2 DKO or DKO hippocampal
neurons infected with the individual rescue constructs were plated at a density of
50,000–100,000 cells onto 6mm sapphire disks for 13–16 days. Neuronal cultures
were frozen using a high-pressure freezer (HPM 100 Leica) under a pressure of
2,100 bar by mounting it into a sandwich support with extracellular solution
containing 15% Ficoll. The cryoﬁxation was achieved within milliseconds allowing
simultaneous immobilization of all macromolecular components. After freezing,
samples were transferred into cryovials containing 1% glutaraldehyde, 1% osmium
tetroxide, 1% ddH2O in anhydrous acetone and processed in an AFS2 automated
freeze-substitution device (Leica) with the following temperature program: 5 h at
 90 C, from  90 C to  20 C (5 C per h), 12 h at  20 C and from  20 C
to 20 C (10 C per h). After freeze substitution, samples were en bloc stained in
0.1% uranyl acetate for 1 h and inﬁltrated in increasing concentration of epoxy
resin (Epon 812, EMS) diluted in acetone at room temperature. Subsequently,
samples were ﬂat embedded in Epon and baked for 48 h at 60 C to allow Epon
polymerization. Approximately 200–300 mm square areas containing neurons were
randomly selected and sectioned at 40–50 nm thickness using an Ultracut UCT
ultramicrotome (Leica) equipped with a diamond knife (Diatome ultra 45).
Ultrathin sections were collected on formvar-coated (0.5%) 200 mesh copper grids
(EMS) and counterstained with 2% uranyl acetate and lead citrate (0.15m lead
nitrate, 0.12m sodium citrate in ddH2O). Sections were examined in a FEI Tecnai
G20 TEM operated at 80–120 keV and digital images were taken with a Veleta
2 K 2K CCD camera (Olympus). EMs (2,048 2,048 pixels) containing a single
synaptic proﬁle were collected blindly at 135,000 magniﬁcation (pixel size
0.38 nm). Data were analysed blindly by using an analysis program developed for
ImageJ and Matlab as reported by Watanabe et al.5 Active zones were deﬁned as
the portion of the presynaptic membrane directly opposite to the postsynaptic
density. Docked synaptic vesicles were deﬁned as vesicles observed to be in direct
contact with the plasma membrane, that is, in the images the contact between
vesicle and plasma membrane was gapless. Three independent Munc13-1/2 DKO
hippocampal neuronal cultures were used for each data set.
Electrophysiology. Synaptic function was assayed by whole-cell voltage clamp from
autaptic hippocampal Munc13-1/2 DKO neurons at 13–16 days in vitro. Synaptic
currents were monitored at room temperature using a Multiclamp 700B ampliﬁer
(Axon Instrument). The series resistance was compensated by 70% and only cells with
series resistances ofo10MO were analysed. Data were acquired using pClamp 10
software (Axon Instrument) at 10 kHz and ﬁltered using a
low-pass Bessel ﬁlter at 3 kHz. Borosilicate glass pipettes with a resistance between
2 and 3.5MO were used and ﬁlled with a solution containing the following (in mM):
136 KCl, 17.8 HEPES, 1 EGTA, 4.6 MgCl2, 4 Na2ATP, 0.3 Na2GTP and 12 creatine
phosphate; 50Uml 1 phosphocreatine kinase; adjusted to pH 7.4 with osmolarity at
B300 mOsm. Neurons were continuously perfused with standard extracellular solu-
tion including the following (in mM): 140 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 2
CaCl2 and 4 MgCl2; adjusted to pH 7.4 with osmolarity atB300 mOsm. AP-evoked
EPSCs were triggered by 2ms somatic depolarization from  70 to 0mV. To deter-
mine the size of the RRP, 500mM sucrose was applied directly onto the isolated
neuron for 5 s using a fast-ﬂow system47. A transient inward current lasting for 2–3 s
that characterizes the release of the RRP is followed by a steady-state current that
indicates the point at which the rates of reﬁlling and release are equal. When the
steady-state current is used as a baseline, the area under the transient curve indicates
the total charge released by the RRP . For vesicular release probability (Pvr )
calculations, the ratio of EPSC charge to RRP charge was determined. Paired-pulse
stimulation protocol contained two inductions of an AP at an interval of 100ms
(10Hz). The paired-pulse ratio was calculated by dividing the amplitude of the second
EPSC by amplitude of the ﬁrst. For phorbol ester experiments, we ﬁrst determined the
RRP size under resting condition. One minute later, EPSC amplitudes were monitored
at 0.2Hz for 30 s. without PDBu application and 30 s under application of 1 mM of
PDBu to determine the degree of EPSC potentiation. Immediately after the application
of PDBu, the RRP size was again measured. Data were analysed ofﬂine using Axograph
X (Axograph Scientiﬁc).
Isothermal titration calorimetry. ITC experiments were performed on a VP-ITC
system (MicroCal) at 20 C in a buffer containing 50mM Tris (pH 7.3), 150mM
NaCl, 5mM MgCl2 and 1mM TCEP as described35. Data were ﬁtted to a single
binding site model using a nonlinear least-squares routine within Origin for ITC
v.5.0 (MicroCal).
Transfection, coimmunoprecipitation and western blotting. HEK293 expres-
sion vectors for Munc13-1 WT and C2A domain mutants were constructed in
pEGFP-N1 (CLONTECH Laboratories). Transgenes were cloned between the
cytomegalovirus promoter and the SV40 polyA sequences. Munc13-1-FLAG was
generated from rat Unc13a by PCR ampliﬁcation with a reverse primer that
harbours a 3xFLAG sequence (Sigma-Aldrich). The RIM-1a cDNA was a gift from
Dr Thomas C Su¨dhof at the Stanford University and RFP sequence was fused to the
C terminus.
HEK293TN (BioCat GmbH) cells were transiently double transfected at 80%
conﬂuency with: (1) Munc13-1 with 3xFLAG fused to the C terminus and
Munc13-1 WT or C2A mutants plasmids with C-terminal GFP tag to detect
C2A–C2A interaction or (2) RIM-1a with RFP fused to the C terminus and
C-terminally GFP-tagged Munc13-1 WT or C2A domain mutants to assess
RIM/Munc13 interaction. After 48 h, cells were washed twice with phosphate-
buffered saline (PBS) and lysed at 4 C with a NP-40 cell lysis buffer containing:
50mM Tris-HCl (pH 7.9), 150mM NaCl, 1% NP-40, 0.5% deoxycholate and 5mM
EDTA and protease inhibitor cocktail-complete mini.
Next, 250 mg of the double transfected lysates were incubated for 30min at
room temperature with protein G-Dynabeads (Thermo Scientiﬁc, Hampton, NH,
USA) bound to the antibody (Ab) Rabbit anti-GFP (Abcam 6556) or control Ab
Rabbit IgG (Cell Signaling 2729S). The Dynabeads-Ab-Antigene (Ag) c were
washed three times with washing buffer and eluted with 25 ml elution buffer. Final
25 ml eluted Dynabeads-Ab-Ag complexes were mixed with 25 ml sample buffer
(Laemmli 2 concentrated containing 0.2M dithiothreitol) and boiled for 10min
at 70 C. Dynabeads were removed after boiling and 25 ml of the
immunoprecipitates and 25 mg protein from the double transfected lysates were
used for the SDS–polyacrylamide gel electrophoresis. Proteins were transferred to
nitrocellulose membranes. After blocking with 5% skim milk in Tris-buffered saline
with Tween-20, blots were incubated with mouse monoclonal ANTI-FLAG M2
(Sigma F1804), Living Colors A.v. monoclonal Ab (JL-8) (Clontech 632380) or
rabbit polyclonal anti RIM1/2 (SYSY 140203) Abs. After washing the blots with
Tris-buffered saline with Tween-20, the immune reactive proteins were detected by
ECL (ECL-plus kit; GE Healthcare Biosciences) with horseradish peroxidase-
coupled secondary Ab (Jackson ImmunoResearch Laboratories). Western blot
images (Fig. 3d) have been cropped for presentation. Full size images are presented
in Supplementary Figs 3 and 5.
Immunocytochemistry. Munc13-1/2 DKO or DKO hippocampal neurons infected
with the different rescue constructs were plated at a density of 25,000 cells and
ﬁxed in 4% paraformaldehyde in PBS at 16 days in vitro. After ﬁxation, neurons
were permeabilized with PBS–Tween 20, blocked with serum in PBS–Tween
20 and incubated overnight with rabbit polyclonal antibody against GFP (1:500;
Abcam 6556) and guinea pig polyclonal antibody VGLUT1 (1:4,000; Synaptic
System, 135304). Primary antibodies were labelled with Alexa Fluor 488 Afﬁnipure
donkey anti-rabbit IgG and Alexa Fluor 647 Afﬁnipure donkey anti-guinea pig IgG
(1:500 each; Jackson ImmunoResearch). Coverslips were mounted with Mowiol
4–88 antifade medium (Polysciences Europe). Fixed neurons were imaged on a
confocal laser-scanning microscope Leica TCS SP8 with identical settings used for
all samples. Neuronal cultures were visualized using a 63 oil immersion objec-
tive. Images were acquired using Leica Application Suite X (LAsX) software at
1,024 1,024 pixels resolution using a z-series projection of 8–10 images with
0.3 mm depth intervals. Ten independent neurons per group for each cultured and
three different cultures were imaged and analysed using ImageJ software.
Statistics. For the statistical analysis data were collected from at least three
independent hippocampal cultures to minimize culture-to-culture variability. To
minimize variability among the electrophysiological data sets, an approximately
equal number of autaptic neurons were recorded from all experimental groups per
day. Electrophysiological data from the different experimental groups during
3–4 consecutive days of recording were normalized to the mean value of the
control group. Data are expressed as mean±s.e.m. Statistical comparison was
performed in all ﬁgures except for Fig. 6 by Kruskal–Wallis one-way analysis of
variance followed by a multiple comparison Dunn’s post hoc test. For the data in
Fig. 6 (PDBu experiment), signiﬁcance and P values were calculated by comparison
with the non-PDBu-treated group using the unpaired Student’s t-test:
Mann–Whitney. Data were acquired and analysed in a blinded fashion and dif-
ferences between data sets were considered signiﬁcant at Po0.05.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author on reasonable request.
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